Literature DB >> 11507329

Soy protein isoflavones, lipids and arterial disease.

M Z Vitolins1, M Anthony, G L Burke.   

Abstract

There is convincing evidence that soybean products have beneficial effects on cardiovascular disease risk factors. Interest in understanding which components of the soybean are responsible for the potential benefits on cardiovascular disease risk factors and the magnitude of their effect continues. This review focuses on the scientific literature published during 1999-2001, evaluating the effects of soy protein isolate, soy foods, and purified isoflavones on plasma lipid concentrations and other cardiovascular disease outcomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507329     DOI: 10.1097/00041433-200108000-00010

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  5 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

2.  Soy protein containing isoflavones favorably influences macrophage lipoprotein metabolism but not the development of atherosclerosis in CETP transgenic mice.

Authors:  Leiko Asakura; Patrícia M Cazita; Lila M Harada; Valéria S Nunes; Jairo A Berti; Alessandro G Salerno; Daniel F J Ketelhuth; Magnus Gidlund; Helena C F Oliveira; Eder C R Quintão
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

3.  Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms.

Authors:  Nica M Borradaile; Linda E de Dreu; Lisa J Wilcox; Jane Y Edwards; Murray W Huff
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

4.  Resistance training with soy vs whey protein supplements in hyperlipidemic males.

Authors:  Carol A Denysschen; Harold W Burton; Peter J Horvath; John J Leddy; Richard W Browne
Journal:  J Int Soc Sports Nutr       Date:  2009-03-11       Impact factor: 5.150

5.  Genistein upregulates LDLR levels via JNK-mediated activation of SREBP-2.

Authors:  Medicia Kartawijaya; Hye Won Han; Yunhye Kim; Seung-Min Lee
Journal:  Food Nutr Res       Date:  2016-05-20       Impact factor: 3.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.